Detalles de la búsqueda
1.
Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation.
Eur J Clin Pharmacol
; 80(4): 529-543, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38252170
2.
Safety and Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome-Diarrhea With or Without Bile Acid Diarrhea: Open-Label Study.
Dig Dis Sci
; 67(8): 3911-3921, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35122592
3.
Considerations in the Selection of Renal Dosage Adjustments for Patients with Serious Infections and Lessons Learned from the Development of Ceftazidime-Avibactam.
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32015049
4.
Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia.
Antimicrob Agents Chemother
; 63(4)2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30670413
5.
A phase I, open-label, single-arm study for QT assessment of eribulin mesylate in patients with advanced solid tumors.
Invest New Drugs
; 31(4): 900-9, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23143778
6.
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Target Attainment Analyses for Dalbavancin in Pediatric Patients.
Pediatr Infect Dis J
; 42(2): 99-105, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36638392
7.
The Safety and Efficacy of Dalbavancin and Active Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections.
Pediatr Infect Dis J
; 42(3): 199-205, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36476623
8.
Population Pharmacokinetic Modeling and Probability of Pharmacodynamic Target Attainment for Ceftazidime-Avibactam in Pediatric Patients Aged 3 Months and Older.
Clin Pharmacol Ther
; 111(3): 635-645, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34687548
9.
Pharmacokinetic and Pharmacodynamic Target Attainment in Adult and Pediatric Patients Following Administration of Ceftaroline Fosamil as a 5-Minute Infusion.
Clin Pharmacol Drug Dev
; 10(4): 420-427, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33465279
10.
Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.
Paediatr Drugs
; 23(6): 549-563, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34462863
11.
Dalbavancin Population Pharmacokinetic Modeling and Target Attainment Analysis.
Clin Pharmacol Drug Dev
; 9(1): 21-31, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31087630
12.
Ceftazidime-Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups.
Clin Transl Sci
; 12(2): 151-163, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30221827
13.
Evaluation of population pharmacokinetics and exposure-response relationship with coadministration of amlodipine besylate and olmesartan medoxomil.
J Clin Pharmacol
; 48(7): 823-36, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18490496
14.
Model-based development of a PPARgamma agonist, rivoglitazone, to aid dose selection and optimize clinical trial designs.
J Clin Pharmacol
; 48(12): 1420-9, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18936283
15.
Asenapine pharmacokinetics and tolerability in a pediatric population.
Drug Des Devel Ther
; 12: 2677-2693, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30214156
16.
Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia.
J Clin Pharmacol
; 57(3): 345-355, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27510635
17.
Correction to: Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.
Paediatr Drugs
; 23(6): 615, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34617260
18.
Exposure-response analysis of pertuzumab in HER2-positive metastatic breast cancer: absence of effect on QTc prolongation and other ECG parameters.
Cancer Chemother Pharmacol
; 72(5): 1133-41, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23999693
19.
Effects of Trastuzumab Emtansine (T-DM1) on QT Interval and Safety of Pertuzumab Plus T-DM1 in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.
Clin Pharmacol Drug Dev
; 2(1): 11-24, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27121556
20.
Model-Supported Development of CS-8635: A Fixed-Dose Combination of Olmesartan, Amlodipine, and Hydrochlorothiazide.
Clin Pharmacol Drug Dev
; 2(2): 103-12, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27121665